Is ZSAN or JNJ a better dividend investment in 2026?

ZSAN currently yields 358.68% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ZSAN offers higher current income.

What is the dividend yield difference between ZSAN and JNJ?

ZSAN has a forward dividend yield of 358.68% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 355.32 percentage points.

Home › Compare › ZSAN vs JNJ

ZSAN vs JNJ: Dividend Comparison 2026

ZSAN yields 358.68% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZSAN wins by $5209.18M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZSAN

● Live price

358.68%

Share price

$0.56

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5209.20M

Annual income

$3,364,155,661.75

Full ZSAN calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ZSAN vs JNJ

📍 ZSAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZSAN	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZSAN + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZSAN pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSAN

Annual income on $10K today (after 15% tax)

$30,487.80/yr

After 10yr DRIP, annual income (after tax)

$2,859,532,312.49/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ZSAN beats the other by $2,859,531,608.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSAN + JNJ for your $10,000?

ZSAN: 50%JNJ: 50%

100% JNJ50/50100% ZSAN

Portfolio after 10yr

$2604.61M

Annual income

$1,682,078,244.76/yr

Blended yield

64.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZSAN

Analyst Ratings

Buy

Hold

Consensus: Buy

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSAN buys

JNJ buys

No recent congressional trades found for ZSAN or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZSANJNJ

Forward yield	358.68% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$5209.20M ✓	$20.0K
Annual income after 10y	$3,364,155,661.75 ✓	$827.78
Total dividends collected	$5034.10M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: ZSAN vs JNJ ($10,000, DRIP)

Year	ZSAN Portfolio	ZSAN Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$46,568	$35,868.01	$10,676	$355.77	+$35.9K → ZSAN
2	$205,931	$156,102.94	$11,407	$389.39	+$194.5K → ZSAN
3	$865,496	$645,150.13	$12,198	$426.53	+$853.3K → ZSAN
4	$3,460,164	$2,534,083.72	$13,056	$467.62	+$3.45M → ZSAN
5	$13,170,607	$9,468,231.28	$13,987	$513.12	+$13.16M → ZSAN
6	$47,774,260	$33,681,710.63	$14,998	$563.56	+$47.76M → ZSAN
7	$165,300,693	$114,182,234.19	$16,098	$619.52	+$165.28M → ZSAN
8	$546,100,449	$369,228,707.89	$17,295	$681.69	+$546.08M → ZSAN
9	$1,724,339,796	$1,140,012,314.98	$18,599	$750.82	+$1724.32M → ZSAN
10	$5,209,199,243	$3,364,155,661.75	$20,022	$827.78	+$5209.18M → ZSAN

ZSAN vs JNJ: Complete Analysis 2026

ZSAN — Stock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSAN Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ZSAN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSAN vs SCHD ZSAN vs JEPI ZSAN vs O ZSAN vs KO ZSAN vs MAIN ZSAN vs ABBV ZSAN vs MRK ZSAN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.